Suchergebnisse - "Koufargyris, Panagiotis"

PubPharm (26)

1

qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in the emergency department : a randomized controlled trial

enthalten in: Critical care (London, England) | 2024

von Adami, M. | Kotsaki, A. | Antonakos, N. | +14

2

qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in the emergency department: a randomized controlled trial

enthalten in: Critical care | 2024

von Adami, M. | Kotsaki, A. | Antonakos, N. | +14

3

Developing a Tool for Differentiation Between Bacterial and Viral Respiratory Infections Using Myxovirus Resistance Protein A and C-Reactive Protein

enthalten in: Infectious diseases and therapy | 2024

von Iliopoulou, K. | Koufargyris, P. | Doulou, S. | +19

4

Developing a Tool for Differentiation Between Bacterial and Viral Respiratory Infections Using Myxovirus Resistance Protein A and C-Reactive Protein

enthalten in: Infectious diseases and therapy | 2023

von Iliopoulou, K. | Koufargyris, P. | Doulou, S. | +19

5

Early Anakinra Treatment for COVID-19 Guided by Urokinase Plasminogen Receptor

enthalten in: bioRxiv.org | 2022

von Kyriazopoulou, E. | Poulakou, G. | Milionis, H. | +52

6

A novel optical biosensor for the early diagnosis of sepsis and severe COVID-19: the PROUD study

enthalten in: ResearchSquare.com | 2022

von Doulou, S. | Leventogiannis, K. | Tsilika, M. | +12

7

An animal model of limitation of gut colonization by carbapenemase-producing Klebsiella pneumoniae using rifaximin

enthalten in: Scientific reports | 2022

von Xenofontos, E. | Renieris, G. | Kalogridi, M. | +6

8

Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity : The ACHIEVE Open-Label Single-Arm Trial

enthalten in: Infectious diseases and therapy | 2021

von Tsiakos, K. | Tsakiris, A. | Tsibris, G. | +28

9

Effect of anakinra on mortality in patients with COVID-19 : a systematic review and patient-level meta-analysis

enthalten in: The Lancet. Rheumatology | 2021

von Kyriazopoulou, E. | Huet, T. | Cavalli, G. | +122

CommentIn: Eur J Intern Med. 2023 Mar;109:117-119. - PMID 36462963

10

Author Correction : Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

enthalten in: Nature medicine | 2021

von Kyriazopoulou, E. | Poulakou, G. | Milionis, H. | +61

ErratumFor: Nat Med. 2021 Oct;27(10):1752-1760. - PMID 34480127